These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 3136330)

  • 1. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
    N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.
    Dyck PJ; Sherman WR; Hallcher LM; Service FJ; O'Brien PC; Grina LA; Palumbo PJ; Swanson CJ
    Ann Neurol; 1980 Dec; 8(6):590-6. PubMed ID: 7212646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
    N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR; Hawthorne JN; Tomlinson DR
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
    Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
    Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.
    Kato N; Mizuno K; Makino M; Suzuki T; Yagihashi S
    Diabetes Res Clin Pract; 2000 Oct; 50(2):77-85. PubMed ID: 10960717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
    Del Monte MA; Rabbani R; Diaz TC; Lattimer SA; Nakamura J; Brennan MC; Greene DA
    Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA; Lattimer-Greene S; Sima AA
    Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of insulin and sorbinil on myoinositol uptake in peripheral nerve from normal and diabetic rats and a neuroblastoma cell line (N1E-115).
    Dunlop ME; Hill MA; Larkins RG
    Diabetes Res; 1988 Jun; 8(2):51-7. PubMed ID: 3147829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic neuropathy--pathogenesis and precipitating factors].
    Wasada T
    Nihon Rinsho; 1991 Feb; 49 Suppl():159-65. PubMed ID: 1851896
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
    Greene DA; Lattimer SA
    Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG; Fathallah L
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
    Lu KM; Zhong XL; Zhu XX; Zhu QY
    Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve glucose, sorbitol, fructose, and myo-inositol at various time after feeding in streptozotocin-induced diabetes in rats.
    Dyck PJ; Minnerath SR; O'Brien PC
    Mayo Clin Proc; 1989 Aug; 64(8):905-10. PubMed ID: 2796400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
    Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
    Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.
    Sima AA; Greene DA; Brown MB; Hohman TC; Hicks D; Graepel GJ; Bochenek WJ; Beg M; Gonen B
    J Diabetes Complications; 1993; 7(3):157-69. PubMed ID: 8343610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.